Medical Device | March 28, 2024
MASH is a chronic and progressive liver disease characterised by fat accumulation and inflammation in the liver,
Launch innovative vitamin sublingual sprays
The agreement is for USFDA approved Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets
To focus on providing safer burn treatments for women and armed forces
Zydus becomes the only Indian oncology player to venture into prognosis and diagnosis along with treatment planning
The partnership will further strengthen Olympus leadership in the diagnosis and staging of liver disease
Infigratinib is not FDA-, Health Canada- or Therapeutics Goods Association-approved for any other indication
Avacc 3 has significant advantages over existing whooping cough vaccines
By strengthening the company's fibrotic disease development pipeline, Bridge will enhance its strategic focus on the development of comprehensive treatment solutions for idiopathic pulmonary fibrosis (IPF)
Subscribe To Our Newsletter & Stay Updated
